$34.74 Bn Interventional Cardiology Market - Global Forecasts from 2025 to 2030: Opportunities in Increasing Prevalence of Cardiovascular Diseases and Shift Towards Minimally Invasive Procedures

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "Interventional Cardiology Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering.

The Interventional Cardiology Market is set to expand from USD 26.096 billion in 2025 to USD 34.742 billion by 2030, with a 5.89% CAGR. This growth is driven by the rising adoption of minimally invasive procedures and a growing prevalence of cardiovascular diseases (CVDs).

Interventional cardiology employs catheter-based techniques to address heart conditions, such as angioplasty and valve repair, providing alternatives to open surgery. The market's expansion is also supported by technological advancements in catheter-based devices. However, stringent regulatory requirements and high procedure costs, especially in developing regions, present challenges to market growth.

Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The persistent global burden of CVDs is a major market driver. As one of the leading causes of death, the demand for advanced treatment options is rising, driving the preference for minimally invasive interventions. The increasing cases of conditions like coronary artery disease and heart valve disorders are bolstering the adoption of catheter-based procedures.

Technological Advancements in Devices

Innovations in cardiology devices, including advanced stents and imaging-guided catheters, are significantly stimulating market growth. These advancements enhance procedural safety and effectiveness, improving management of complex cardiovascular conditions.

Increasing Health Expenditure Worldwide

The rise in global healthcare expenditure supports market growth, particularly in developed and emerging economies. Investments in healthcare infrastructure and advanced medical technologies are fostering wider adoption of these procedures.

Market Restraints

Stringent Regulatory Requirements

The rigorous regulatory scrutiny required for device approvals can slow market entry and increase development costs, posing challenges for manufacturers.

High Cost in Developing Economies

The high cost of procedures and devices limits accessibility in developing regions, restricting market penetration and hindering growth.

Market Segmentation and Geographical Outlook

The market is segmented geographically, with North America and Europe leading due to advanced healthcare systems. Asia-Pacific is projected for significant growth, driven by rising healthcare investments and improving treatment access.

Key Players

Major market players include Medtronic, Stryker, Abbott, among others, focusing on innovation and strategic partnerships to maintain competitive advantage.

Industry Outlook

The market is set for sustained growth, fueled by rising CVDs, technological advancements, and increasing healthcare investments. Despite challenges, the alignment with minimally invasive trends promises significant expansion, particularly in Asia-Pacific.

Key Benefits of this Report:

• Insightful analysis covering major and emerging regions and market dynamics.
• Understanding competitive strategies for market penetration.
• Explore future trends impacting market developments.
• Actionable insights for strategic decisions and revenue generation.
• Beneficial for a wide audience, including startups and large enterprises.

What do businesses use our reports for?

Industry insights, market entry strategy, geographical expansion, and competitive intelligence.

Report Coverage:

• Historical and forecast data from 2022 to 2030.
• Growth opportunities, challenges, and regulatory framework.
• Competitive positioning and market share analysis.
• Revenue growth and forecast assessment.
• Company profiling and key developments.

Segmentation

• By Device Type
  • Stents
    • Drug-Eluting Stents (DES)
    • Bare-Metal Stents (BMS)
    • Bioabsorbable Stents
  • Catheters
    • Diagnostic Catheters
    • Guiding Catheters
  • Percutaneous Transluminal Coronary Angioplasty Balloons
    • Plain Old Balloon Angioplasty (POBA)
    • Cutting/Scoring Balloons
• By Application
  • Coronary Artery Disease
  • Heart Valve Disease
• By End-User
  • Hospitals and Clinics
  • Specialty Cardiac Centers
• By Geography
  • North America
  • Europe
  • Asia-Pacific

Key Attributes:

Companies Featured

• Medtronic
• Stryker
• Abbott
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cordis
• Edwards Lifesciences Corporation
• GE Healthcare
• Biosensors International Group, Ltd.
• Biotronik, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/fgfpro

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Interventional Cardiology Market